株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

免疫学の研究戦略:大きな潜在性を持った発展する市場、しかし克服すべき困難な障害を伴う

Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

発行 CBR Pharma Insights 商品コード 278108
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
免疫学の研究戦略:大きな潜在性を持った発展する市場、しかし克服すべき困難な障害を伴う Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome
出版日: 2013年07月30日 ページ情報: 英文
概要

当レポートでは、免疫療法市場における課題、動向および将来の展望について分析し、免疫治療薬の開発の動向と発売戦略、主な研究領域、失敗例からの教訓、および主要企業などをまとめ、概略以下の構成でお届けします。

エグゼクティブサマリー

免疫療法の概要

  • 歴史
  • 主要技術

免疫治療薬の開発・発売戦略

  • 初期段階の調査
  • 治験設計
  • 規制の検討事項
  • 市場アクセス
    • ケーススタディ:プロベンジ

免疫治療薬の開発の動向

  • 現在の焦点は癌
  • その他の研究中の疾病
    • 多発性硬化症
    • アレルギー
    • アルツハイマー病

免疫治療薬市場

  • 市場予測
  • 主要企業
  • 免疫治療薬
  • 過去の失敗例からの教訓
  • 研究
  • 将来の展望

付録

目次
Product Code: CBRSV046

Abstract

Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.

The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing.

Market access presents a significant hurdle for immunotherapeutics, as many are high cost and do not deliver the measurements required for traditional costeffectiveness assessments.

Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this market but also due to the critical role the immune system plays in the proliferation of cancer throughout the body. Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated.

The report, "Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome" was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike.

image1

Key Reasons to Purchase

image2

  • Access CBR's insights and analysis on the opportunities which exist within this complicated and fast moving market
  • Better understand where both the main opportunities and challenges exist to successfully developing an immunotherapeutic product and what it will take to get there
  • Gain a more complete picture of the where the trends in development are taking the future of immunotherapeutics
  • Utilize CBR's case study analysis to help support key business decisions
  • Benefit from CBR's identification and discussion on the lessons learned when developing an immunotherapeutic product and our outlook on the future of the market


Table of Contents

Executive summary

Methodology

Immunotherapy Overview

  • History
  • Key technologies

Immunotherapeutic Development and Launch Strategies

  • Early stage research
  • Clinical trial design
  • Regulatory considerations
  • Market access
    • Case study - Provenge

Trends in the Development of Immunotherapeutics

  • Oncology is the current focus
  • Other diseases being researched
    • Multiple Sclerosis
    • Allergy
    • Alzheimer's Disease

The Immunotherapeutics Market

  • Market forecast
  • Key Companies Involved in
  • Immunotherapeutics
  • Lessons learned from past failures - Case
  • studies
  • Future Outlook

Appendix

Back to Top